Rachael Lester insider trades

Open-market stock purchases and sales by Rachael Lester, Chief Business Officer at CytomX Therapeutics, Inc, from SEC Form 4 filings since Oct 20, 2025.

Recent trades

DateStockTradeValue
Feb 2, 2026CTMX CytomX Therapeutics, IncBought (not open market)—
Feb 2, 2026CTMX CytomX Therapeutics, IncBought (not open market)—

Companies traded

  • CTMX CytomX Therapeutics, Inc: other filings, last Feb 2, 2026

Get free alerts when Rachael Lester files a new trade →